Histone acetylation: a key determinant of acquired cisplatin resistance in cancer
Abstract Cisplatin is an alkylating class of chemotherapeutic drugs used to treat cancer patients. However, cisplatin fails in long-term treatment, and drug resistance is the primary reason for tumor recurrence. Hence, understanding the mechanism of acquirement of chemoresistance is essential for de...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-01-01
|
| Series: | Clinical Epigenetics |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13148-023-01615-5 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|